<DOC>
	<DOCNO>NCT00546260</DOCNO>
	<brief_summary>Safety efficacy adjunctive antiplatelet therapy prior primary percutaneous intervention ( PCI ) patient ST-Elevation Myocardial Infarction ( STEMI )</brief_summary>
	<brief_title>Safety Efficacy Study Adjunctive Antiplatelet Therapy Prior Primary PCI Patients With STEMI</brief_title>
	<detailed_description>Patients STEMI undergo primary PCI randomize intravenous ( iv ) bolus placebo vs. PRT060128 prior angiography .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Persistent ST elevation ≥ 1mm ( ≥ 0.1mV ) two contiguous limb lead OR ≥ 2 mm ( ≥ 0.2mV ) two contiguous precordial lead , AND chest pain ≥ 20 minute onset within 6 hour hospital presentation . Cardiogenic shock ( systolic blood pressure &lt; 90 mm Hg require vasopressor hemodynamic support ) Uncontrolled hypertension define measure systolic blood pressure ( SBP ) &gt; 180 mm Hg diastolic blood pressure ( DBP ) ≥ 110 mm Hg time History symptom congenital acquire bleed disorder vascular malformation . Recent gastrointestinal bleeding within last 30 day . Known thrombocytopenia ( platelet count &lt; 100,000/mm3 ) . Any treatment fibrinolytic agent within last 7 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>STEMI</keyword>
	<keyword>ACS</keyword>
</DOC>